These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14065358)

  • 1. PHLEBOTOMY FOR MODERATE ERYTHROCYTHEMIA. IMPROVEMENT IN PERIPHERAL CIRCULATION AND MYOCARDIAL FUNCTION IN PATIENTS WITH OBLITERATIVE ARTERIAL DISEASE OF THE LOWER EXTREMITIES.
    CRANLEY JJ; FOGARTY TJ; KRAUSE RJ; STRASSER ES; HAFNER CD
    JAMA; 1963 Oct; 186():206-10. PubMed ID: 14065358
    [No Abstract]   [Full Text] [Related]  

  • 2. POLYCYTHEMIA VERA: PERIPHERAL VASCULAR MANIFESTATIONS.
    MOORE WS; BLAISDELL FW; HALL AD
    Calif Med; 1964 Feb; 100(2):92-6. PubMed ID: 14123656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(5):441-54. PubMed ID: 9387203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
    Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hematocrit and viscosity on coronary circulation and myocardial oxygen utilization.
    Kuramoto K; Matsushita S; Matsuda T; Mifune J; Sakai M; Iwasaki T; Shinagawa T; Moroki N; Murakami M
    Jpn Circ J; 1980 Jun; 44(6):443-8. PubMed ID: 7401273
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
    Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
    Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular events and intensity of treatment in polycythemia vera.
    Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
    N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC; Wang J
    Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycythemia vera, the hematocrit, and blood-volume physiology.
    Spivak JL
    N Engl J Med; 2013 Jan; 368(1):76-8. PubMed ID: 23216617
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.
    Fujioka S
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):688-95. PubMed ID: 2618545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CURRENT METHOD OF BLOOD COAGULATION TESTS IN POLYCYTHEMIA VERA].
    NAGY I; BURGER T
    Orv Hetil; 1964 Aug; 105():1501-2. PubMed ID: 14180938
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib mesylate (Gleevec(TM)) reduces phlebotomy requirements in polycythemia vera.
    Silver RT
    Leukemia; 2003 Jun; 17(6):1186-7. PubMed ID: 12764388
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of hematocrit on blood viscosity].
    Leblond PF; Lacasse M; Morillon M; Huot-Petitclerc MC
    Union Med Can; 1983 Jan; 112(1):22-5. PubMed ID: 6836773
    [No Abstract]   [Full Text] [Related]  

  • 16. Postnatal alteration in hematocrit and viscosity in normal and polycythemic infants.
    Ramamurthy RS; Berlanga M
    J Pediatr; 1987 Jun; 110(6):929-34. PubMed ID: 3585609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
    Barbui T; Carobbio A; De Stefano V; Alvarez-Larran A; Ghirardi A; Carioli G; Fenili F; Rossi E; Ciceri F; Bonifacio M; Iurlo A; Palandri F; Benevolo G; Pane F; Ricco A; Carli G; Caramella M; Rapezzi D; Musolino C; Siragusa S; Rumi E; Patriarca A; Cascavilla N; Mora B; Cacciola E; Calabresi L; Loscocco GG; Guglielmelli P; Gesullo F; Betti S; Ramundo F; Lunghi F; Scaffidi L; Bucelli C; Cattaneo D; Vianelli N; Bellini M; Finazzi MC; Tognoni G; Rambaldi A; Vannucchi AM
    Ann Hematol; 2024 Feb; 103(2):437-442. PubMed ID: 38060001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ON THE HEMODYNAMICS IN POLYCYTHEMIA VERA].
    PALU CD; CORA D; DEBIASI S; CASSON F
    Z Kreislaufforsch; 1963 Oct; 52():1019-27. PubMed ID: 14095661
    [No Abstract]   [Full Text] [Related]  

  • 19. INCIDENCE OF CLINICAL CRITERIA OF ATHEROSCLEROSIS IN HYPO- AND HYPERTHYROIDISM, POLYCYTHAEMIA VERA AND CHRONIC COR PULMONALE (PARA- AND ANTIATHEROSCLEROTIC SYNDROMES).
    ROGUSKI J; DURKALEC J; HASIK J; JAROSZEWSKI F; KRASNIK W; NOWACZYK J; RACHLEWICZ J; ROGUSKA J; RUSZKOWSKI M
    Cor Vasa; 1964; 6():219-30. PubMed ID: 14177021
    [No Abstract]   [Full Text] [Related]  

  • 20. Hearing improvement induced by phlebotomy in polycythemia.
    Davis EC; Nilo ER
    Laryngoscope; 1965 Dec; 75(12):1847-52. PubMed ID: 5854616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.